10x Genomics, Inc.
TXGMedical Devices
$81.55−2.48%As of Oct 29vs prior close
- Market cap
- $10.6B
- P/E (TTM)
- –
- P/E (FY1)
- 2223.9×
- From 52W high
- −16.56%
- EPS (LTM)
- -$0.59
- Revenue (LTM)
- $616.9M
- Net margin
- -12.18%
- Dividend yield
- 0.00%
Nomior Score
57
Crowded AscentTop 34% of the scored universe
Growth51
Quality54
Value29
Momentum100
Resilience40
Growth
+31.69%revenue a year over 8 fiscal years
YE17 $71.1MLTM $616.9M
Connections
Revenue to profitQ2 FY26
The operating loss was 13% of revenue, wider by 30 pts on a year.
Who owns it
2funds, 1 tracked portfolio